Yahoo France Recherche Web

  1. Should you pass or buy Johnson & Johnson? Zacks experts tell all in a free Special Report. Free report pulls back the curtain on what's happening with JNJ. Grab your free copy.

Résultats de recherche

  1. 28 juin 2024 · 7.51. 7.67. 7.53. Upgrade. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed cash flow statements for Johnson & Johnson (JNJ), including operating cash flow, capex and free cash flow.

  2. Il y a 5 jours · Part of Kenvue, Inc., Johnson & Johnson Santé Beauté France SAS is a company based in Issy-les-Moulineaux, France. Johnson & Johnson Santé Beauté France SAS is a major player in well-being, aiming to take care of people in their diversity, to live fully and healthy. The French company was founded in 2004. Bruno Portalier has been the CEO of ...

  3. Il y a 5 jours · RBC Raises Price Target on Johnson & Johnson to $181 From $178, 'Encouraged' by Enterprise Business Review, Keeps Outperform Rating Dec. 06: MT UBS Upgrades Johnson & Johnson to Buy From Neutral, Raises Price Target to $180 From $167 Dec. 01: MT

  4. Il y a 5 jours · Inghan, et al. v. Johnson & Johnson et al. was one of the earliest talcum powder lawsuits. It was filed in the Circuit Court for the City of St. Louis (a very plaintiff-friendly venue) by 22 women who alleged that they developed ovarian cancer from prolonged use of J& talcum powder products. The two specific J&J talcum powder products named in ...

  5. Il y a 4 jours · Ho sostenuto un colloquio presso Johnson & Johnson. Colloquio. Screening -> 1st interview (with hiring managers), questions based on your resume & common interview questions -> 2nd interview (with executives), relaxed, chilling atmosphere but unique, tricky questions -> Get results. Domande di colloquio [1] Domanda 1.

  6. Il y a 5 jours · Johnson & Johnson: Veränderung des Consensus und Kursziel der Analysten Aktie Johnson & Johnson | 853260 | US4781601046 | Nyse

  7. Il y a 3 jours · 3.01%. 4.23%. Upgrade. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Financial ratios and metrics for Johnson & Johnson (JNJ). Includes annual, quarterly and trailing numbers with full history and charts.

  1. Recherches liées à johnson & johnson

    vaccin johnson & johnson